Home

H3K27

H3K27 refers to the lysine 27 residue on histone H3, a site on the N-terminal tail that can be modified by methylation or acetylation. These chemical marks influence chromatin structure and gene activity, helping to regulate transcription across development and differentiation.

Methylation at H3K27 is primarily carried out by the Polycomb Repressive Complex 2 (PRC2), with EZH2 as

Acetylation at H3K27 (H3K27ac) marks active regulatory elements, particularly enhancers and, to a lesser extent, promoters.

Biological significance includes roles in development, X-chromosome inactivation, and cancer. Experimental methods to study H3K27 modifications

the
catalytic
subunit
(and
EZH1
in
some
contexts).
H3K27
can
be
mono-,
di-,
or
trimethylated
(H3K27me1/2/3),
with
H3K27me3
serving
as
a
hallmark
of
facultative
heterochromatin
and
transcriptional
repression.
This
mark
is
recognized
by
other
Polycomb
components,
including
PRC1,
which
helps
compact
chromatin
and
maintain
silenced
states.
Demethylases
such
as
KDM6A
(UTX)
and
KDM6B
(JMJD3)
can
remove
methyl
groups,
enabling
gene
activation
during
development
or
in
response
to
signals.
In
embryonic
stem
cells,
genes
important
for
development
often
exhibit
bivalent
domains
containing
both
H3K27me3
and
the
activating
mark
H3K4me3,
signifying
poised
regulation.
This
modification
is
deposited
by
histone
acetyltransferases
such
as
CBP
and
p300
and
is
associated
with
open
chromatin
and
transcriptional
activation.
Deacetylation
by
histone
deacetylases
can
reverse
the
mark,
contributing
to
dynamic
regulation
of
gene
expression.
The
balance
between
H3K27me3
and
H3K27ac
influences
developmental
gene
programs
and
cell
fate
decisions.
include
chromatin
immunoprecipitation
followed
by
sequencing
(ChIP-seq)
and
related
approaches
like
CUT&RUN.